Role of oxidative stress in cocaine-induced cardiotoxicity and cocaine-related death

Current Medicinal Chemistry

Volumn 19, Issue 33, 2012, Pages 5619-5623

  Cerretani, D ^a   Fineschi, V ^b   Bello, S ^b   Riezzo, I ^b   Turillazzi, E ^b   Neri, M ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Antioxidant enzymes; Apoptosis; Cardiotoxicity; Cocaine related death; Oxidative stress; Reactive Oxygen Species

Indexed keywords

COCAINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL DAMAGE; COCAINE DEPENDENCE; DISEASE MODEL; DRUG FATALITY; ENZYME ACTIVITY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RISK FACTOR;

ANIMALS; CARDIOTOXINS; CARDIOVASCULAR DISEASES; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; HEART; HUMANS; MYOCARDIUM; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84869497356     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803988785     Document Type: Article

References (41)

1. Vasica G., Tennant C. C. Cocaine use and cardiovascular complications. Med. J. Aust., 2002, 177, 260-262.
2. Darke S., Kaye S., Duflou J. Comparative cardiac pathology among deaths due to cocaine toxicity, opioid toxicity and non-drug-related causes. Addiction., 2006, 101, 1771-1777.
3. Afonso L., Mohammad T., Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am. J. Cardiol. 2007, 100, 1040-1043.
4. Lange R. A., Hillis L. D. Cardiovascular complications of cocaine use. New. Engl. J. Med., 2001, 345(5), 351-358.
5. Kloner R. A., Hale S., Alker K., Rezkalla S. The effects of acute and chronic cocaine use on the heart. Circulation 1992, 85, 407-419.
6. Sofuoglu M., Nelson D., Babb D. A., Hatsukami D. K. Intravenous cocaine increases plasma epinephrine and norepinephrine in myocardial dysfunction, but complementary experimental humans. Pharmacol. Biochem. Behav. 2001, 68(3), 455-459.
7. Singal P. K., Khaper N., Palace V., Kumar D. The role of oxidative stress in the genesis of heart disease. Cardiovasc. Res., 1998, 40(3), 426-432.
8. Tappia P. S., Hata T., Hozaima L., Sandhu M. S., Panagia V., Dhalla N. S. Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca transport. Arch. Biochem. Biophys., 2001, 387(1), 85-92.
9. Devi B. G., Chan A. W. Effect of cocaine on cardiac biochemical functions. J. Cardiovasc. Pharmacol. 1999, 33(1), 1-6.
10. Fineschi V., Baroldi G., Centini F., Cerretani D., Fiaschi A. I., Micheli L. Parolini M., Turillazzi E., Giorgi G. Markers of cardiac oxidative stress and altered morphology after intraperitoneal cocaine injection in a rat model. Int. J. Legal. Med., 2001, 114, 323-330.
11. Bolli R., Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev., 1999, 79(2), 609-634.
12. Griendling K. K., Sorescu D., Ushio-Fukai M. NAD (P) H oxidase: role in cardiovascular biology and disease. Circ. Res., 2000, 86(5), 494-501.
13. Mohazzab H., Kaminski P. M., Wolin M. S. Lactate and PO2 modulate NADPH oxidase expression at the transcriptional level. role of NADH oxidase. Circulation 1997, 96(2), 614-620.
14. Fukui T., Yoshiyama M., Hanatani A., Omura T., Yoshikawa J., Abe Y. Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochem. Biophys. Res. Commun. 2001, 281(5), 1200-1206.
15. Bendall J. K., Cave A. C., Heymes C., Gall N., Shah A. M. Pivotal role of a gp91 (phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation, 2002, 105(3), 293-296.
16. Boess F., Ndikum-Moffor F. M., Boelsterli U. A., Roberts S. M. Effects of cocaine and its oxidative metabolites on mitochondrial respiration and generation of reactive oxygen species. Biochem. Pharmacol,. 2000, 60, 615-623.
17. Kovacic P. Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. Med. Hypotheses., 2004, 64, 350-356.
18. Pacifici R., Fiaschi A. I., Micheli L., Centini F., Giorgi G., Zuccaro P., Pichini S., Di Carlo S., Bacosi A., Cerretani D. Immunosuppression and oxidative stress induced by acute and chronic exposure to cocaine in rat. Int. Immunopharmacol., 2003, 3, 581-592.
19. Zhang L., Xiao Y., He J. Cocaine and apoptosis in myocardial cells. Anat. Rec., 1999, 257, 208-216.
20. Sugden P. H., Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun. N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ. Res., 1998, 83, 345-352.
21. Dhalla K. S., Rupp H., Beamish R. E., Dhalla N. S. Mechanisms of alterations in cardiac membrane Ca2+ transport due to excess catecholamines. Cardiovasc. Drugs. Ther., 1996, 10(1), 231-238.
22. Bindoli A., Rigobello M. P., Galzigna L. Toxicity of aminochromes. Toxicol. Lett., 1989, 48(1), 3-20.
23. Singal P. K., Yates J. C., Beamish R. E., Dhalla N. S. Influence of reducing agents on adrenochrome-induced changes in the heart. Arch. Pathol. Lab. Med., 1981, 105(12), 664-9.
24. Behonick G. S., Novak M. J., Nealley E. W., Baskin S. I. Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). J. Appl. Toxicol., 2001, 21(1), S15-22.
25. Hargrave B. Y., Tiangco D. A., Lattanzio F. A., Beebe. S. J. Cocaine, not morphine, causes the generation of reactive oxygen species and activation of NF-kappaB in transiently cotransfected heart cells. Cardiovasc. Toxicol., 2003, 3, 141-151.
26. Moritz F., Monteil C., Isabelle M., Bauer F., Renet S., Mulder P., Richard V., Thuillez C. Role of reactive oxygen species in cocaine-induced cardiac dysfunction. Cardiovasc. Res., 2003, 59, 834-843.
27. Sutliff R. L., Cai G., Gurdal H., Snyder D. L., Roberts J., Johnson M. D. Cardiovascular hypertrophy and increased vascular contractile responsiveness following repeated cocaine administration in rabbits. Life Sci., 1996, 58(8), 675-82.
28. Besse S., Assayag P., Latour C., Janmot C., Robert V., Delcayre C., Nahas G., Swynghedauw B. Molecular characteristics of cocaine-induced cardiomyopathy in rats. Eur. J. Pharmacol., 1997, 338(2), 123-9.
29. Brickner M. E., Willard J. E., Eichhorn E. J., Black J., Grayburn P. A. Left ventricular hypertrophy associated with chronic cocaine abuse. Circulation, 1991, 84, 1130-1135.
30. Moritz F., Monteil C., Isabelle M., Mulder P., Henry J. P., Derumeaux G., Richard V., Muller J. M., Thuillez C. Selenium diet-supplementation improves cocaine-induced myocardial oxidative stress and prevents cardiac dysfunction in rats. Fundam. Clin. Pharmacol., 2004, 18(4), 431-6.
31. Stadtman T. C. Selenium-dependent enzymes. Annu. Rev. Biochem., 1980, 49, 93-110.
32. Moritz F., Monteil C., Mulder P., Derumeaux G., Bizet C., Renet S., Lallemand F., Richard V., Thuillez C. Prolonged cardiac dysfunction after withdrawal of chronic cocaine exposure in rats. J. Cardiovasc. Pharmacol., 2003, 42(5), 642-7.
33. Castelli M. C., Venturini L., Sparber S. B. Cocaine and salicylate: documentation of hydroxyl radical formation in hearts and brains of 18-day-old chick embryos and unexpected interactive toxicity. Psychopharmacology, 2001, 156, 23-31.
34. Isabelle M., Monteil C., Moritz F., Dautreaux B., Henry J. P., Richard V., Mulder P., Thuillez C. Role of alpha1-adrenoreceptors in cocaine-induced NADPH oxidase expression and cardiac dysfunction. Cardiovasc. Res., 2005, 67, 699-704.
35. Kono Y., Fridovich I. Superoxide radical inhibits catalase. J. Biol. Chem., 1982, 257, 5751-5754.
36. Vergeade A., Mulder P., Vendeville-Dehaudt C., Estour F., Fortin D., Ventura-Clapier R., Thuillez C., Monteil C. Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: Prevention by the targeted antioxidant MitoQ. Free Radical Biology And Medicine, 2010, 49(5), 748-756.
37. Isabelle M., Vergeade A., Moritz F., Dautréaux B., Henry J. P., Lallemand F., Richard V., Mulder P., Thuillez C., Monteil C. NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. J. Mol. Cell. Cardiol., 2007, 42(2), 326-32.
38. Fan L., Sawbridge D., George V., Teng L., Bailey A., Kitchen I., Li JM. Chronic cocaine-induced cardiac oxidative stress and mitogen-activated protein kinase activation: the role of Nox2 oxidase. J. Pharmacol. Exp. Ther., 2009, 328(1), 99-106.
39. Li J. M., Shah A. M. Endothelial cell superoxide generation: Regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2004, 287, R1014-R1030.
40. Sinha-Hikim I., Shen R., Nzenwa I., Gelfand R., Mahata S. K., Sinha-Hikim A. P. Minocycline suppresses oxidative stress and attenuates fetal cardiac myocyte apoptosis triggered by in utero cocaine exposure. Apoptosis, 2011, 16, 563-573.
41. Domínguez-Rodríguez A., Abreu-González P., Enjuanes-Grau C., Blanco-Palacios G., Angeles Pérez-Carrillo Mde L., Burillo-Putze G. Oxidative stress and inflammatory markers in cocaine users with acute coronary syndrome. Med. Clin. (Barc)., 2010, 134(4), 152-155.